The Association between Glyceraldehyde-Derived Advanced Glycation End-Products and Colorectal Cancer Risk

Area of Science:

• Oncology
• Metabolic Health
• Dietary Science

Background:

• Colorectal cancer (CRC) is linked to lifestyle factors like obesity and hyperglycemia.
• These factors may increase toxic carbonyls, such as glyceraldehyde.
• Glyceraldehyde-derived advanced glycation end-products (glycer-AGEs) are implicated in CRC via inflammation and oxidative stress.

Purpose of the Study:

• To investigate the association between circulating glycer-AGEs and colorectal cancer risk.
• To explore potential differences in this association between colon and rectal cancer.

Main Methods:

• A nested case-control study with 1,055 CRC cases and matched controls.
• Circulating glycer-AGEs measured using competitive ELISA.
• Multivariable logistic regression adjusted for confounders like BMI, smoking, and diabetes.

Main Results:

• No significant association was found between elevated glycer-AGEs and overall CRC risk.
• Subgroup analysis indicated no association with colon cancer (OR 0.83).
• A positive association was observed for rectal cancer (OR 1.90).

Conclusions:

• Circulating glycer-AGEs are not associated with colon cancer risk.
• A positive association exists between circulating glycer-AGEs and rectal cancer risk.
• Further research is needed on carbohydrate metabolism products in CRC development.